The five most common treatment-related adverse events were pleural effusion (n = 13, 28.2%), increased AST/ALT (n = 11, 24.4%), anemia (n = 10, 22.2%), fever (n = 9, 20.0%), and pneumothorax (n = 9, 20.0%). This evidence concerns the gene GPT and Pleural effusion.